Please login to the form below
personalised medicines
This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.
Greater Manchester backs move to outcome-based payment
able to access new and innovative medicines as early as possible and delivering better value for money.”. ... We’re set to see more personalised medicines being launched over the next few years, so additional data will help ensure those treatments
Latest news
-
CAR-Ts go head-to-head after NICE clears Kymriah in DLBCL
Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE said: “Recommending another revolutionary CAR T-cell therapy for adults with lymphoma represents a step forward for personalised medicine. ... Providing the latest cutting
-
Hancock says UK genome service is now ‘rolling out’
The news was welcomed by Mike Thompson, chief executive of the Association of the British Pharma Industry (ABPI), who said: “The health secretary’s focus on earlier diagnosis and more personalised ... medicines for cancer and rare diseases is great
-
Novartis cuts manufacturing jobs in Switzerland and UK
Chief executive Vas Narasimhan says the cuts are part of Novartis’ strategy to move away from high-volume drug production towards more specialised and personalised medicines.
-
UK pharma to work with innovation network on NHS uptake
The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of medicines and other 'biomedical innovations' ... These areas include economic growth, digital
-
GSK: we won’t be splitting up any time soon
prescription medicines businesses. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance personalised medicines research throughout its pipeline.
More from news
Approximately 13 fully matching, plus 54 partially matching documents found.
Latest Intelligence
-
The first, my last, my everything
This growing empowerment arguably has its biggest impact in the arena of high-value medicines. ... We need a better understanding of patients. We’re heading rapidly towards personalised medicines, yet we’re still not personalising the value that we
-
Genomics integration: can the NHS rise to the challenge?
We can then make sure personalised medicine treatment is targeted to the individual so they get the best treatment at the right point in time. ... Last year, NHS England announced that it will focus on earlier diagnosis and more personalised medicines
-
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
National Institute for Health Research (NIHR) and the UK’s medicines regulator the MHRA. ... The partnership will aim to enable faster and more efficient drug research, generate more robust evidence to support treatment value, and ultimately provide
-
Cell and gene therapy
In the case of a personalised therapy like CAR-T, the cost of the raw materials, the components and the labour that goes into manufacturing, testing and logistics are all for ... For traditional biopharmaceutical products one batch equals many doses,
-
Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?
In recent years, biosimilars (highly similar copies of biologic medicines) have taken large shares of many markets. ... It follows that the next generation of relationship holders, representing very expensive but ultra-personalised medicines like CAR-Ts
More from intelligence
Approximately 4 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Eduardo Bravo becomes head of EBE
Coming from the field of advanced therapies, he helps bridge the gap between the lab and personalised medicines within a thriving and innovative ecosystem.”.
-
Horizon Discovery appoints executive director
1996. Horizon is a UK-based biotech focused on genomics research and the development of personalised medicines.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
'Fake news': battling misinformation in healthcare
As the pharmaceutical landscape becomes more complex and as personalised and precision medicines emerge, these stories are increasingly impacting patients and healthcare professionals.
-
Mastering the precision medicine opportunity
Personalised: Developing and choosing medicines that will change the patient experience, from one of hope to one of certainty of response. ... In personalised medicine, we ask if we can use a particular treatment in a patient.
-
Medopad: the up and coming unicorn transforming remote patient monitoring
The company has developed a platform for creating modular apps which can be personalised across numerous patient cohorts, using a combination of artificial intelligence, rich data analysis and a strong understanding ... Healthcare is becoming more precise
-
Medicines personalised for Tom, Dick and Harry
And so enters the concept of personalised medicine with the aim of providing treatments to ever-shrinking populations of high responders. ... Perhaps more radical ideas need to be considered to deliver personalised medicine that is both equitable and
-
Being Human - The healthcare angle
The industry is busily developing innovative, often personalised medicines, but we’re under unprecedented scrutiny.
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
Featured jobs
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Havas Life Medicom
We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
